Chemoinformaics analysis of 4-HYDROXY-BENZOIC-ACID
| Molecular Weight | 342.435 | nRot | 10 |
| Heavy Atom Molecular Weight | 316.227 | nRig | 13 |
| Exact Molecular Weight | 342.183 | nRing | 2 |
| Solubility: LogS | -4.844 | nHRing | 0 |
| Solubility: LogP | 5.989 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 51 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 25 | No. of Aromatic Carbocycles | 2 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 12 |
| nHA | 4 | APOL | 55.6146 |
| nHD | 1 | BPOL | 30.4234 |
| QED | 0.359 |
| Synth | 1.777 |
| Natural Product Likeliness | -0.065 |
| NR-PPAR-gamma | 0.083 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.049 |
| Pgp-sub | 0 |
| HIA | 0.004 |
| CACO-2 | -4.925 |
| MDCK | 0.0000229 |
| BBB | 0.078 |
| PPB | 1.00178 |
| VDSS | 0.636 |
| FU | 0.00873274 |
| CYP1A2-inh | 0.353 |
| CYP1A2-sub | 0.179 |
| CYP2c19-inh | 0.785 |
| CYP2c19-sub | 0.061 |
| CYP2c9-inh | 0.445 |
| CYP2c9-sub | 0.972 |
| CYP2d6-inh | 0.253 |
| CYP2d6-sub | 0.765 |
| CYP3a4-inh | 0.197 |
| CYP3a4-sub | 0.135 |
| CL | 9.37 |
| T12 | 0.407 |
| hERG | 0.3 |
| Ames | 0.014 |
| ROA | 0.033 |
| SkinSen | 0.955 |
| Carcinogencity | 0.34 |
| EI | 0.963 |
| Respiratory | 0.218 |
| NR-Aromatase | 0.858 |
| Antiviral | No |
| Prediction | 0.551749 |